PsyBio Therapeutics Company Description

PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States.

PsyBio Therapeutics Corp. was formerly known as Leo Acquisitions Corp. and changed its name to PsyBio Therapeutics Corp. in January 2021.

The company is headquartered in Denver, Colorado.

PsyBio Therapeutics Corp.

Country	Canada
Industry	Biotechnology
Sector	Healthcare
CEO	Evan Levine

Contact Details

Address: 1624 Washington Street Denver, British Columbia 80203 United States
Phone	513 449 9585
Website	psybiolife.com

Stock Details

Ticker Symbol	PSYBF
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	CA6936971044
SIC Code	2836

Key Executives

Name	Position
Evan Mike Levine	Co-Founder, Chief Executive Officer and Chairman
Dr. Michael Spigarelli M.B.A., M.B.E., M.D., Ph.D.	Chief Scientific Officer and Chief Medical Officer
Ross Carmel	Chief Legal Officer and Director
Noah Isidore Davis	Secretary and Director
Andrew Jones	Inventor and Chairman of Scientific Advisory Board